08 September 04
Changes in classification of medicinal products (terbinafine)
According to the decision of the State Agency of Medicines topical terbinafin preparations with maximum concentration of 1% and with the package size 15 g or 15 ml will be switched from the list of prescription only medicines to OTC medicines as of October 1, 2004.
The decision concerns the following preparations authorised in Estonia:
GEDEON RICHTER Ltd. TERBISIL 1% KREEM cream 1% 15g Novartis Finland OY LAMISIL cream 1% 7,5 g, 15 g Novartis Finland OY LAMISIL cutaneous spray, solution1% 15 ml Novartis Finland OY LAMISIL DERMGEL gel 1% 5g; 15g
The indication for the above preparations is: Tinea pedis
May interactions of the sun and medicines cause dangerous skin reactions?
a) yes, several medicines may give interactions with the sun
b) yes, but it doesn't apply to solarium
c) no, sunbathing is safe
Results
Results